Paradigm Biopharmaceuticals Ltd.ASX: PAR

Phase 3 Knee OA Trial Recruiting and Dosing in AUS & US

Sep 30, 2025 at 5:07 AM UTC · Issued by Paradigm Biopharmaceuticals Ltd.

Paradigm Biopharmaceuticals Ltd has released a press release.

View Attachment